Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 14NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 4Lymphoid 3Thoracic 1Sarcoma 1Other hematologic neoplasm 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 168Lung Neoplasms 148Adenocarcinoma of Lung 37Small Cell Lung Carcinoma 23Adenocarcinoma, Bronchiolo-Alveolar 20Breast Neoplasms 15Mesothelioma, Malignant 13Colorectal Neoplasms 11Colonic Neoplasms 10Prostatic Neoplasms 9Rectal Neoplasms 7Ovarian Neoplasms 7Breast Neoplasms, Male 7Neoplasm Metastasis 6Melanoma 6Carcinoma, Ovarian Epithelial 6Thymoma 5Pleural Effusion, Malignant 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Pain 4Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Salivary Gland Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Esthesioneuroblastoma, Olfactory 3Esophageal Neoplasms 3

Interventions

Proton Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Cardiotoxicity × Thoracic × Clear all
NCT04822077 2021-03-30

PROTHYM

Swedish Lung Cancer Study Group

Phase NA Recruiting
40 enrolled
Thoracic

Thymoma, Thymus Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡